Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Shenghan Xu"'
Autor:
Shenghan Xu, Miao Liu, Jiamu Xu, Bangwei Che, Wenjun Zhang, Wei Li, Tao Huang, Ying Yu, Cheng Zha, Zheng Peng, Kunyuan Huang, Kaifa Tang
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
This case report shares the management experience of a patient with pregnancy combined with adrenal adenoma causing ACTH-independent Cushing’s syndrome (CS), accompanied by obstetric antiphospholipid syndrome (OAPS) and severe pre-eclampsia. The ca
Externí odkaz:
https://doaj.org/article/8b9500e65e684931b953127d9c8b2f86
Autor:
Cheng Zha, Zheng Peng, Kunyuan Huang, Kaifa Tang, Qiang Wang, Lihua Zhu, Bangwei Che, Wei Li, Shenghan Xu, Tao Huang, Ying Yu, Wenjun Zhang
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
The gut microbiota helps to reveal the relationship between diseases, but the role of gut microbiota in prostate cancer (PCa) is still unclear. Recent studies have found that the composition and abundance of specific gut microbiota are significantly
Externí odkaz:
https://doaj.org/article/cac08e43908e42bc8c0f35df3af91a70
Autor:
Bangwei Che, Wenjun Zhang, Wei Li, Kaifa Tang, Jingju Yin, Miao Liu, Shenghan Xu, Tao Huang, Ying Yu, Kunyuan Huang, Zheng Peng, Cheng Zha
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundThe composition of the tumor microbial microenvironment participates in the whole process of tumor disease. However, due to the limitations of the current technical level, the depth and breadth of the impact of microorganisms on tumors have
Externí odkaz:
https://doaj.org/article/7dbf46d2105b4ee1bff1edf2b9d0f735
Autor:
Shenghan Xu, Ying Yu, Yajuan Zhang, Yong Wen, Wei Li, Tao Huang, Bangwei Che, Wenjun Zhang, Jinjuan Zhang, Kaifa Tang
Publikováno v:
Frontiers in Surgery, Vol 9 (2022)
ObjectiveThis study shares our experience in managing adrenal schwannoma (AS).MethodsThe clinical data of eight patients with AS in our hospital from April 2007 to April 2022 were analyzed retrospectively.ResultsA total of 1309 patients with adrenal
Externí odkaz:
https://doaj.org/article/728fdee47d344ff88cd9009b67cb14a5
Autor:
Bangwei Che, Wenjun Zhang, Shenghan Xu, Jingju Yin, Jun He, Tao Huang, Wei Li, Ying Yu, Kaifa Tang
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Although the incidence and mortality of prostate cancer have gradually begun to decline in the past few years, it is still one of the leading causes of death from malignant tumors in the world. The occurrence and development of prostate cancer are af
Externí odkaz:
https://doaj.org/article/83088d8051f445a08779586d0396649a
Publikováno v:
Advanced Intelligent Systems, Vol 3, Iss 12, Pp n/a-n/a (2021)
Local or national crises, such as natural disasters, major infrastructure failures, and pandemics, pose dire threats to manufacturing. The concept of a rideshare‐like distributed network of consumer‐type 3D printers is proposed to address the lim
Externí odkaz:
https://doaj.org/article/d470b8f4edc149e2a9e28f34ad75348a
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundPartial nephrectomy (PN) is the recommended treatment for T1 renal cell carcinoma (RCC). Compared with suture PN, sutureless PN reduces the difficulty and time of operation, but the safety and feasibility have been controversial. This meta-
Externí odkaz:
https://doaj.org/article/256931f909ae4e3e89c0136880d741de
Publikováno v:
Molecules, Vol 27, Iss 17, p 5594 (2022)
Prostate cancer (PCa) is the most common malignant tumor of the male urinary system in Europe and America. According to the data in the World Cancer Report 2020, the incidence rate of PCa ranks second in the prevalence of male malignant tumors and va
Externí odkaz:
https://doaj.org/article/1761cb5c40bb43fa8ec704bd1201d3f4
Autor:
MIAO LIU1, SHENGHAN XU1, JUN HE1, YI MU1, KEHANG CHEN1, WENJUN ZHANG1, BANGWEI CHE1, KAIFA TANG1,2 tangkaifa@gmc.edu.cn
Publikováno v:
Molecular & Clinical Oncology. Oct2022, Vol. 17 Issue 4, p1-6. 6p.
Autor:
Shenghan Xu, Audrey Tan
Publikováno v:
International Journal of Economics, Business and Management Studies. 10:1-9
U.S. demographic change brings new product offerings, production planning, and distribution challenges. While many companies embrace diversity, inclusion, and ethnicity product offering, their practice often renders mixed results, potentially negativ